Leading the Innovation Revolution Xentria Inc's Unstoppable Momentum

Xentria, Inc. (Xentria), a clinical-stage biotherapeutics company focused on advancing drug development to address unmet medical needs ... Xentria - Developer of therapeutics for treating cancer, metabolic diseases & musculoskeletal diseases. Raised a total funding of $25M over 1 round. Xentria is a biotech company based in Illinois that specializes in building authentic life-sciences partnerships to drive innovative drug and intellectual ... Xentria, Inc. 224-443-4615 [email protected]. Brief Summary: A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis. Read more. Recent Posts ... Illinois' biotechnology sector continues to demonstrate its growing prominence with Xentria, Inc., a Chicago-based clinical-stage ... Tianjin Hemay Pharmaceutical Co Ltd, Hainan Hailing Chemipharma Corporation Ltd ... Xentria Inc, Sarcoidosis, Pulmonary, Details. SAR-442970, SAR-442970, Phase 2 ... Xentria Investigative Site. Budapest, Hungary, 1077. Enrolling. Contact site. Central trial contact. Xentria Inc. Xentria Inc. Contact trial ... Xentria will be eligible for potential royalties exceeding $600 million throughout the agreement. ... company, Hong-Kong King Friend Industry Co. Xentria ... Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat ... Xentria Inc., a Chicago-based biotech company, opened its new corporate headquarters in Lincoln Park this week. The company also secured a ...